Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NEK9 |
| Upstream (Parents) |
|---|
| (<<) SRSF5 → NEK9 |
| (<<) NCOA2 → NEK9 |
| (<<) BTD → NEK9 |
| (<<) ZFY///ZFX → NEK9 |
| (<<) SEC23A → NEK9 |
| (<<) C10orf28 → NEK9 |
| Downstream (Children) |
|---|
| NEK9 → WWOX (>>) |
| NEK9 → SRSF5 (>>) |
| NEK9 → SLC4A3 (>>) |
| NEK9 → PAK7 (>>) |
| NEK9 → WNT1 (>>) |
| NEK9 → CACNG2 (>>) |
| NEK9 → GJA8 (>>) |
| NEK9 → LOC730909///LOC390561 (>>) |
| NEK9 → ALPI (>>) |
| NEK9 → DCHS1 (>>) |
| NEK9 → CYTH1 (>>) |
| NEK9 → CPEB1 (>>) |
| NEK9 → MED28 (>>) |
| NEK9 → HNRNPH1 (>>) |
| NEK9 → MED16 (>>) |
| NEK9 → GRK6 (>>) |
| NEK9 → ZFY///ZFX (>>) |
| NEK9 → FNTB (>>) |
| NEK9 → HMBOX1 (>>) |
| NEK9 → FAM108B1 (>>) |
| NEK9 → C10orf28 (>>) |
